ONDINE BIOPHARMA Corp — Form D
ONDINE BIOPHARMA Corp of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2009-12-29. The offering totals $239K, of which $239K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-12-29
- Form: D
- Accession: 0001286774-09-000007
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $239K
- Amount sold: $239K
- Investors: 2
- Date of first sale: 2009-12-23
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-64540
Issuer
- Name: ONDINE BIOPHARMA Corp
- CIK: 0001286774
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 910-1100 MELVILLE ST, VANCOUVER, A1, V6E4A6
- Phone: 604-669-0555
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Nicolas Loebel | Executive Officer | Vancouver, A1 |
| Michael Crane | Director | Austin, TX |
| William Harper | Executive Officer | Little Rock, AR |
| Merrill Biel | Director | San Diego, CA |
| COLIN WATT | Director | VANCOUVER, A1 |
| Carolyn Cross | Director | Vancouver, A1 |
| Carolyn Cross | Executive Officer | Vancouver, A1 |
| Thomas Dawson | Executive Officer | Vancouver, A1 |
| Terence Holland | Director | Vancouver, A1 |
| Margaret Shaw | Director | Vancouver, A1 |
| Nicholas Loebel | Executive Officer | Vancouver, A1 |
Other filings by this issuer (3)
More